ArticleScientific reports2022

Hepatitis C virus NS3/4A inhibitors and other drug-like compounds as covalent binders of SARS-CoV-2 main protease.

Babak Andi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.